Oral metronomic chemotherapy is a therapeutic option which is particularly attractive due to its ease of administration and low toxic burden. Its mechanism of action probably involves antiangiogenetic effect rather than a classical antiproliferative effect like standard maximally tolerated dose-based regimens.
Gebbia, V., Boussen, H., Valerio, M. (2012). Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma. ANTICANCER RESEARCH, 32(2), 529-536.
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma
GEBBIA, Vittorio;VALERIO, Maria Rosaria
2012-01-01
Abstract
Oral metronomic chemotherapy is a therapeutic option which is particularly attractive due to its ease of administration and low toxic burden. Its mechanism of action probably involves antiangiogenetic effect rather than a classical antiproliferative effect like standard maximally tolerated dose-based regimens.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
529.full.pdf
Solo gestori archvio
Descrizione: articolo
Dimensione
124.61 kB
Formato
Adobe PDF
|
124.61 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
